Suppr超能文献

通过微针贴片递送流感疫苗的机遇与挑战

Opportunities and challenges in delivering influenza vaccine by microneedle patch.

作者信息

Jacoby Erica, Jarrahian Courtney, Hull Harry F, Zehrung Darin

机构信息

PATH, PO Box 900922, Seattle, WA 98109, USA.

HF Hull & Associates, 1200 Riverside Dr., Reno, NV 89503, USA.

出版信息

Vaccine. 2015 Sep 8;33(37):4699-704. doi: 10.1016/j.vaccine.2015.03.062. Epub 2015 Apr 1.

Abstract

INTRODUCTION

Simple and efficacious delivery methods for influenza vaccines are needed to improve health outcomes and manage possible pandemics both in the United States and globally. One approach to meeting these needs is the microneedle patch (MNP), a small array of micron-scale needles that is applied to the skin like a bandage.

METHODS

To inform additional technical developments and the eventual introduction of MNPs for influenza vaccination, we interviewed key opinion leaders in the United States for insights into the opportunities and challenges associated with this technology, particularly its potential for self-administration.

RESULTS

All interviewees expressed high support for administration of influenza vaccine in MNPs by health care providers and for self-administration in groups supervised by a provider. Self-administration via prescription and over-the-counter purchase of MNPs received lower levels of support. Interviewees also highlighted priorities that should be considered in the ongoing development of an influenza vaccine MNP, such as confirming efficacy and ensuring safety for self-administration. For patient and health care provider acceptability, important attributes are ease of use, short wear times, and an easily accessible application site.

DISCUSSION AND CONCLUSIONS

Stakeholders agreed that using MNPs can help increase coverage, facilitate easy and safe delivery, reduce the cost of vaccination, and decrease the global morbidity and mortality associated with influenza. Another opportunity for this delivery method is the potential for self-administration. The prospect of reduced provider training requirements, increased thermostability, and high patient and provider acceptability makes it an attractive option for use in remote and low-resource settings worldwide. However, in addition to the technological challenges associated with producing the patch, developers must be mindful of cost considerations and key product attributes or requirements, such as usability, wear time, and proper disposal, that can affect how the product will be received in the marketplace.

摘要

引言

需要简单有效的流感疫苗接种方法,以改善美国乃至全球的健康状况,并应对可能出现的大流行。满足这些需求的一种方法是微针贴片(MNP),它是一小排微米级的针头,像绷带一样贴在皮肤上。

方法

为了为微针贴片用于流感疫苗接种的进一步技术开发及最终推广提供参考,我们采访了美国的关键意见领袖,以深入了解与该技术相关的机遇和挑战,尤其是其自我接种的潜力。

结果

所有受访者都对医疗保健人员使用微针贴片接种流感疫苗以及在医护人员监督下的群体自我接种表示高度支持。通过处方和非处方购买微针贴片进行自我接种获得的支持较少。受访者还强调了在流感疫苗微针贴片的持续开发中应考虑的优先事项,例如确认自我接种的有效性和确保安全性。对于患者和医疗保健人员的可接受性而言,重要的特性是使用方便、佩戴时间短以及接种部位易于触及。

讨论与结论

利益相关者一致认为,使用微针贴片有助于提高疫苗接种覆盖率,便于安全接种,降低接种成本,并减少全球与流感相关的发病率和死亡率。这种接种方式的另一个机遇是自我接种的潜力。减少医护人员培训要求、提高热稳定性以及患者和医护人员的高接受度,使其成为全球偏远和资源匮乏地区颇具吸引力的选择。然而,除了与生产贴片相关的技术挑战外,开发者还必须考虑成本因素以及关键的产品特性或要求,如易用性、佩戴时间和正确处置方式,这些会影响产品在市场上的接受程度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验